Analgesic efficacy of two different interventions in patients posted for laparoscopic cholecystectomy surgeries

Efficacy of subcostal transversus abdominis plane block and port site infiltration technique in laparoscopic cholecystectomy for post operative analgesia - NIL

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/083486

Enrollment

Registered

2025-03-26

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system Health Condition 2: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

Intervention1: Subcostal TAP block in laparoscopic cholecystectomy surgeries: 20 ml of 0.25% bupivacaine for subcostal TAP block bilaterally Control Intervention1: Port site infiltration technique: 20

Eligibility

Inclusion criteria

Inclusion criteria: Patients of ASA grade I and II Age group 18-60 years of either sex All patients scheduled for elective laparoscopic cholecystectomy surgery

Exclusion criteria

Exclusion criteria: Pregnancy Patients with coagulopathies/on anti-coagulants Seizure disorder History of allergy to related drugs Patients with history of cardiac, respiratory, hepatic or renal failure

Design outcomes

Primary

Measure	Time frame
To determine the analgesic efficacy of ultrasound guided subcostal transversus abdominis plane block and conventional port site infiltration in patients posted for laparoscopic cholecystectomy surgeriesTimepoint: At 0, 2, 4, 8, 12, 16 and 24 hours	—

Secondary

Measure	Time frame
To determine the total rescue analgesic consumption in 24 hours post surgeryTimepoint: At 0, 2, 4, 8, 12, 16 and 24 hours;To determine the duration of analgesia after TAP blockTimepoint: At 0, 2, 4, 8, 12, 16 and 24 hours;To determine the variation in hemodynamic parametersTimepoint: At 0, 2, 4, 8, 12, 16 and 24 hours	—

Countries

India

Contacts

Public ContactDr Jaideep Singh

GMC, Bhopal

awasya.84@gmail.com9200314936

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026